Literature DB >> 18395451

Muscle atrophy associated with multiple sclerosis: a benign condition or the onset of amyotrophic lateral sclerosis?

Jeffrey A Allen1, Robert Stein, Richard A Baker, H Royden Jones.   

Abstract

When muscular atrophy develops in multiple sclerosis (MS) patients, its etiology may vary from benign to serious. We describe an individual with a 24-year history of MS who developed amyotrophic lateral sclerosis (ALS). The literature is reviewed with particular attention to the clinical and electrophysiologic characteristics of patients with MS and muscular atrophy and to those rare patients with concurrent MS and ALS. Circumstances warranting a heightened suspicion for concurrent ALS are discussed and careful evaluation of similar patients is encouraged.

Entities:  

Mesh:

Year:  2008        PMID: 18395451     DOI: 10.1016/j.jocn.2007.04.024

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  5 in total

Review 1.  Pharmacology of manipulating lean body mass.

Authors:  Patricio V Sepulveda; Ernest D Bush; Keith Baar
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-01       Impact factor: 2.557

2.  Co-Occurrence of Multiple Sclerosis and Amyotrophic Lateral Sclerosis in an FUS-Mutated Patient: A Case Report.

Authors:  Luigi Fiondella; Francesco Cavallieri; Elena Canali; Maria Paola Cabboi; Alessandro Marti; Francesca Sireci; Alena Fiocchi; Gloria Montanari; Sara Montepietra; Franco Valzania
Journal:  Brain Sci       Date:  2022-04-21

3.  No evidence for shared genetic basis of common variants in multiple sclerosis and amyotrophic lateral sclerosis.

Authors:  An Goris; Jessica van Setten; Frank Diekstra; Stephan Ripke; Nikolaos A Patsopoulos; Stephen J Sawcer; Michael van Es; Peter M Andersen; Judith Melki; Vincent Meininger; Orla Hardiman; John E Landers; Robert H Brown; Aleksey Shatunov; Nigel Leigh; Ammar Al-Chalabi; Christopher E Shaw; Bryan J Traynor; Adriano Chiò; Gabriella Restagno; Gabriele Mora; Roel A Ophoff; Jorge R Oksenberg; Philip Van Damme; Alastair Compston; Wim Robberecht; Bénédicte Dubois; Leonard H van den Berg; Philip L De Jager; Jan H Veldink; Paul I W de Bakker
Journal:  Hum Mol Genet       Date:  2013-11-13       Impact factor: 6.150

4.  Evaluation of follistatin as a therapeutic in models of skeletal muscle atrophy associated with denervation and tenotomy.

Authors:  Patricio V Sepulveda; Séverine Lamon; Adam Hagg; Rachel E Thomson; Catherine E Winbanks; Hongwei Qian; Clinton R Bruce; Aaron P Russell; Paul Gregorevic
Journal:  Sci Rep       Date:  2015-12-11       Impact factor: 4.379

Review 5.  Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases.

Authors:  Christine Brütting; Alexander Emmer; Malte E Kornhuber; Martin S Staege
Journal:  Biomed Res Int       Date:  2017-02-23       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.